PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

39,980 stories, page 358 of 667

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Acurx's ~550-Patient Trial Could Support C. diff Treatment, Recurrence Reduction

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI?

The Motley FoolOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Weight Loss Approved Drugs: Evidence-Based Options for Safe, Sustainable Results *9RAcMCjbF*

fcbayern.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Proposes Restrictions on Compounding Popular Weight Loss Medications - View tFixTzV5Q

Diario ASOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Beyond seasonal suffering: Effects of Pollen on Cardiorespiratory Health and Allergies

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: European Health Data and Evidence Network

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Uncovering the epigenetic signature of female-specifiC biological networks and key driver genes of coronary ArteRy diseasE

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: From pathobioLogy to synoviA on chip: driving rheuMatoId arthritis to the precisioN medicine GOal

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: A European Cancer Image Platform Linked to Biological and Health Data for Next-Generation Artificial Intelligence and Precision Medicine in Oncology

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approved Weight Loss Patch: Is It a Myth or a Realistic Option? - View wfOLTo9h9

FC BayernOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting the 3Rs

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

US biotech firm: Human trials for COVID-19 vaccine could be held in Israel

JNS.orgOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

WHO Launches Global Framework to Decarbonise Pharma Sector

Healthcare DigitalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Helus Pharma's New CEO Led a $14.6B Sale to Johnson & Johnson

Stock TitanOriginal source
🇺🇸Industryinvestor.lilly.comTier 1 · Company source

Lilly's olomorasib receives U.S. FDA's Breakthrough Therapy designation for the treatment of previously treated KRAS G12C-mutant advanced pancreatic cancer

Eli Lilly NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Zevra Therapeutics Announces Publication of Four-Year Real-World Data from U.S. Early Access Program Evaluating MIPLYFFA® (arimoclomol) in Niemann-Pick Disease Type C (NPC)

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech stock falls 7% on revenue miss despite earnings beat

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Bombay HC Revokes FDA Suspension Of Navi Mumbai Hotel, Considers Costs Over Delay Despite 100 Per Cent

Free Press JournalOriginal source
🇺🇰Researchmft.nhs.ukTier 2 · Direct publisher

Targeted nurse-led clinic launches in Manchester to promote personalised transplant care and tackle inequity in post-transplant outcomes

Manchester University NHS Foundation TrustOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BioNTech appoints Guido Oelkers as new Chief Executive Officer

europeanpharmaceuticalreview.comOriginal source
🇺🇸Industryinvestors.abeonatherapeutics.comTier 1 · Company source

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Abeona TherapeuticsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Earnings call transcript: Concord Biotech misses Q1 2026 estimates

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Belite Bio presents updated phase 3 data on oral tinlarebant for Stargardt

Glance by Eyes On EyecareOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech Q2 Net Income, Product Revenue Rise; Shares Down Pre-Bell

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech (KRYS) Q2 2026 Earnings

24/7 Wall St.Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Opus Genetics Completes Enrollment in Phase 3 Trial of OPGx-LCA5 for LCA5-Associated Inherited Retinal Disease

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Ocular Therapeutix Reports Q2 2026 Results, Confirms Q4 2026 AXPAXLI NDA Submission Plan for Wet AMD

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech 2Q 2026: Revenue $119.22M, EPS $1.79— 10-Q Summary

TradingViewOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech Q2 revenue rises to $119.2 million on VYJUVEK sales

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Krystal Biotech, Inc. Quarterly Earnings Report

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CHO perfusion model lifts yield by letting cellular waste build up

europeanpharmaceuticalreview.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Opus Genetics expects data in 2027 from one-time gene therapy trial

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Opus Genetics Completes Patient Enrollment in

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What would it take to get peptides on the shelf?

NPROriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Panel Ignites Debate Over Controversial Peptide Treatments

streamlinefeed.co.keOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Can-Fite Launches First Clinical Program for Piclidenoson in the Rare Genetic Disease Lowe Syndrome

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Safe Weight Loss Drugs - View oD49QcCT3

fcbayern.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Over the Counter Weight Loss Medication: What Works, What Doesn’t, and How to Pick a Safe Option in 2026 *0oSGFEEPg*

fcbayern.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Harbour BioMed and Kelun-Biotech receive China IND approval for bispecific asthma therapy

BioSpectrum AsiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

IPO News - IPO Winners & Losers: Biotech Soars, Jersey Mike's Misses, and SpaceX Faces the Lockup

renaissancecapital.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Administrative – Government’s restrictions on mifepristone are arbitrary and capricious

Virginia Lawyers WeeklyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Retatrutide Weight Loss Jacksonville - View HburRYuVY

FC BayernOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Partnership to create AI chemical data ecosystem

Scientist LiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approved Weight Loss Patch: What It Is and Why It Matters (or Doesn't) - View rwF6IMi5Z

Diario ASOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Exec on Execs: China's Rise in Biotech Investment

Pharmaceutical ExecutiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

116,100 Shares in Teva Pharmaceutical Industries Ltd. $TEVA Bought by Militia Capital Management LLC

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Varda Announces Biopharma Leader Mikael Dolsten will Join Board as Space-Based Pharmaceutical Manufacturing Accelerates

PR NewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

This Next-Gen GLP-1 Is Blowing Up the Black Market Economy

Marie ClaireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

South Africa Prepares for Potential New Adult TB Vaccine

Newcastillian NewsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Jeol launches two high-resolution microscopes

Scientist LiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Radiopharm (ASX:RAD) Expands Clinical Momentum with Positive Trial Updates

Kalkine MediaOriginal source
🌍Mediacentogene.comTier 2 · Direct publisher

CENTOGENE APAC Expands Commitment to Taiwan’s Rare Disease Community

CentogeneOriginal source
🌍discoverynews.google.comTier 2 · Trade media

What will health and social care look like under Andy Burnham?

pharmaceutical-technology.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Retatrutide Weight Loss Price: What It Costs in 2026 and Why It Matters - View 9UjQdSwbZ

as.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Weight Loss - View BUEiBWgjg

FC BayernOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

IMPACT licenses ovarian cancer drug senaparib to Pharmanovia

The Pharma LetterOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

FDA Approved Weight Loss Medications List - View UYywmxlnc

FC BayernOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Unlocking peptide permeability with high-throughput SFC-EPSA analysis

europeanpharmaceuticalreview.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Breast Cancer Trial Highlights Promise and Risks of Dual Immunotherapy

Technology NetworksOriginal source